全文获取类型
收费全文 | 2056篇 |
免费 | 120篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 45篇 |
妇产科学 | 26篇 |
基础医学 | 258篇 |
口腔科学 | 30篇 |
临床医学 | 240篇 |
内科学 | 349篇 |
皮肤病学 | 37篇 |
神经病学 | 94篇 |
特种医学 | 173篇 |
外科学 | 272篇 |
综合类 | 72篇 |
一般理论 | 1篇 |
预防医学 | 250篇 |
眼科学 | 160篇 |
药学 | 111篇 |
1篇 | |
中国医学 | 3篇 |
肿瘤学 | 58篇 |
出版年
2021年 | 21篇 |
2019年 | 20篇 |
2018年 | 29篇 |
2017年 | 26篇 |
2016年 | 20篇 |
2015年 | 62篇 |
2014年 | 88篇 |
2013年 | 93篇 |
2012年 | 115篇 |
2011年 | 119篇 |
2010年 | 56篇 |
2009年 | 63篇 |
2008年 | 117篇 |
2007年 | 112篇 |
2006年 | 125篇 |
2005年 | 112篇 |
2004年 | 85篇 |
2003年 | 100篇 |
2002年 | 83篇 |
2001年 | 31篇 |
2000年 | 20篇 |
1999年 | 32篇 |
1998年 | 26篇 |
1997年 | 23篇 |
1996年 | 24篇 |
1995年 | 30篇 |
1994年 | 33篇 |
1993年 | 16篇 |
1992年 | 19篇 |
1991年 | 13篇 |
1990年 | 17篇 |
1989年 | 15篇 |
1988年 | 18篇 |
1987年 | 21篇 |
1986年 | 15篇 |
1985年 | 27篇 |
1984年 | 19篇 |
1983年 | 15篇 |
1982年 | 11篇 |
1981年 | 17篇 |
1980年 | 17篇 |
1979年 | 17篇 |
1978年 | 16篇 |
1977年 | 17篇 |
1974年 | 11篇 |
1948年 | 11篇 |
1947年 | 13篇 |
1946年 | 16篇 |
1945年 | 14篇 |
1944年 | 10篇 |
排序方式: 共有2182条查询结果,搜索用时 218 毫秒
1.
2.
3.
Ulrich Weber Christian WA Pfirrmann Rudolf O Kissling Juerg Hodler Marco Zanetti 《BMC musculoskeletal disorders》2007,8(1):20
Background
Ankylosing spondylitis is a chronic inflammatory rheumatic disorder which usually begins in early adulthood. The diagnosis is often delayed by many years. MR imaging has become the preferred imaging method for detection of early inflammation of the axial skeleton in ankylosing spondylitis. 相似文献4.
5.
W J Thompson P S Anderson S F Britcher T A Lyle J E Thies C A Magill S L Varga J E Schwering P A Lyle M E Christy 《Journal of medicinal chemistry》1990,33(2):789-808
A series of 73 dibenzo[a,d]cycloalkenimines were synthesized and evaluated for their ability to displace (+)-10,11-dihydro-5-methyl-5H-dibenzo[a,d]cyclohepten-5,10-imine ([3H]-(+)-10) from its specific binding site on rat cortical membranes. A number of the more active compounds (Ki ranging from 0.006 to 0.21 microM) were evaluated for N-methyl-D-aspartate (NMDA) antagonist activity in the rat cortical slice (Kb ranging from 0.08 to 0.9 microM) and anticonvulsant activity in the mouse against NMDA induced convulsions. The ED50 values ranged from 0.22 to 7.76 mg/kg and correlated reasonably well with the Kb determination. In the dibenzo[a,d]cyclohepten-5,10-imine series, the (+)-5S,10R enantiomer displayed consistently higher levels of biological activity. While substitution at the 3-position of (+)-10 with electronegative atoms generally increased in vitro activity, a loss of potency relative to (+)-10 (MK-801) was observed in vivo for all of the compounds tested. 相似文献
6.
Charles R. Ashby Yoshio Minabe Alon Toor Lyle D. Fishkin Martin I. Granoff Rex Y. Wang 《Drug development research》1994,31(3):228-236
This study examined the effect of acute and chronic administration of the selective 5-HT3 receptor antagonist BRL 46470A, an analog of granisetron, on the number of spontaneously active dopamine (DA) cells in the substantia nigra pars compacta (A9 or SNC) and the ventral tegmental area (A10 or VTA) in the rat. In the A10 area, the acute administration of BRL 46470A decreased the number of spontaneously active DA cells at a dose of 0.1 mg/kg (0.28 μmol/kg) ip, yet increased the number of spontaneously active DA cells at a dose of 0.3 mg/kg (0.84 μmol/kg). The chronic administration (21 days) of BRL 46470A appeared to produce a multiphasic dose-response curve. Thus, the chronic treatment with BRL 46470A increased the number of spontaneously active A10 DA cells at 0.03 (0.084 μmol) and 0.3 mg/kg, but decreased the number of spontaneously active A10 DA cells at a dose of 0.1 mg/kg. In contrast, BRL 46470A did not decrease the number of spontaneously active A9 DA cells after either acute or chronic administration (0.01-0.3 mg/kg). However, BRL 46470A did increase the number of spontaneously active A9 DA cells at acute and chronic doses similar to those that were effective in A10. The iv administration of (+)-apomorphine (APO) not only failed to reverse the decrease produced by chronic administration of BRL 46470A at 0.1 mg/kg, but further decreased the number of spontaneously active A10 DA cells. Similar to the results obtained with granisetron, the pretreatment of naive rats with either 0.01 or 0.1 mg/kg iv of BRL 46470A significantly potentiated (2-fold) the suppressant action of APO on the basal firing rate of A10, but not A9 DA cells. Overall, our results indicate that similar to granisetron, chronic BRL 46470A at 0.1 mg/kg selectively decreases the number of spontaneously active A10 DA cells, via a mechanism not related to depolarization inactivation. Presently, it is not clear what factors may contribute to the multiphasic dose-response curve of BRL 46470A. © 1994 Wiley-Liss, Inc. 相似文献
7.
8.
9.
10.